Biotek-snakken — Oktober 2023
-
ALK-Abelló med positive resultater fra studier med behandling af træpollenallergi hos børn https://www.proinvestor.com/investornyt/1062086/alk-abello-med-positive-resultater-fra-studier-med-behandling-af-traepollenallergi-hos-born
-
Kort video..Pharma- og biotek opdatering..Novo Nordisk har været oppe og ramme kurs 700. Genmab har længe har været kursmæssigt svag og falder yderligere i dag pga. hold-anbefaling fra Nordea. Bavarian Nordic er igen i ilden, efter selskabets CEO meldte ud i et interview på Finans.dk, at selskabet nu ændrer de strategi. Og så er kursen på Hansa Biopharma faldet voldsomt efter en melding om meget skuffende salgstal. https://www.proinvestor.com/boards/116103
-
Svensk biotekselskab rekrutterer første patient til genopstartet studie https://www.proinvestor.com/investornyt/1066130/svensk-biotekselskab-rekrutterer-forste-patient-til-genopstartet-studie
-
Cathie Wood Just Doubled Down on This Biotech Stock. Should You Follow Her Lead? https://www.proinvestor.com/investornyt/1066786/cathie-wood-just-doubled-down-on-this-biotech-stock-should-you-follow-her-lead
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind